— Know what they know.
Not Investment Advice

SHC NASDAQ

Sotera Health Company
1W: -0.7% 1M: -3.9% 3M: +2.0% YTD: +3.0% 1Y: +12.5% 3Y: +21.0% 5Y: -30.4%
$18.22
+0.10 (+0.55%)
 
Weekly Expected Move ±2.9%
$17 $18 $18 $19 $19
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 41 · $5.2B mcap · 154M float · 1.68% daily turnover · Short 63% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.3 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 10.6%  ·  5Y Avg: 1.1%
Cost Advantage ★
68
Intangibles
36
Switching Cost
41
Network Effect
43
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. SHC shows a Weak competitive edge (45.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 10.6% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$25
Low
$25
Avg Target
$25
High
Based on 1 analyst since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$25.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-09-08 Piper Sandler Jason Bednar $24 $25 +1 +33.4% $18.73
2026-06-24 UBS — Initiated $19 — +19.9% $15.84
2026-06-05 Goldman Sachs Evie Koslosky $17 $20 +3 +28.5% $15.57
2026-04-14 Barclays — $20 $18 -2 +14.6% $15.70
2026-01-09 Piper Sandler Jason Bednar $17 $24 +7 +27.6% $18.81
2026-01-08 RBC Capital Ryan Halstead $17 $24 +7 +27.6% $18.81
2025-11-05 Piper Sandler — $13 $17 +4 +5.3% $16.15
2025-11-05 Barclays — $19 $20 +1 +21.7% $16.43
2025-10-02 Barclays — $17 $19 +2 +17.4% $16.19
2025-05-05 Goldman Sachs Matthew Sykes $8 $17 +9 +31.6% $12.92
2024-12-05 Jefferies David Windley $18 $15 -3 +15.6% $12.98
2024-11-06 Jefferies David Windley $14 $18 +4 +17.9% $15.27
2024-08-06 Barclays Luke Sergott $14 $17 +3 +19.5% $14.22
2024-06-06 Jefferies David Windley $16 $14 -1 +21.0% $11.98
2024-05-21 Piper Sandler Jason Bednar Initiated $13 — +19.2% $10.91
2024-05-03 RBC Capital Sean Dodge Initiated $17 — +55.8% $10.91
2024-04-10 Barclays Luke Sergott $22 $14 -8 +20.5% $11.62
2024-03-24 Jefferies David Windley Initiated $16 — +29.9% $11.94
2023-06-26 Loop Capital Markets Matthew Mishan Initiated $24 — +29.1% $18.59
2023-01-10 Wolfe Research Mike Polark Initiated $25 — +44.9% $17.25
2023-01-10 Barclays Luke Sergott $6 $22 +16 +27.5% $17.25
2022-11-23 Goldman Sachs — Initiated $8 — -1.4% $8.12
2022-11-15 Barclays — Initiated $6 — -15.9% $7.13

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 02, 2026
DCF
1
ROE
5
ROA
5
D/E
1
P/E
2
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. SHC receives an overall rating of B-. Strongest factors: ROE (5/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (1/5), P/E (2/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C+ B-
2026-08-12 B- C+
2026-08-06 C+ B-
2026-05-14 B- C+
2026-05-05 C+ B-
2026-03-12 C C+
2026-02-26 C+ C
2026-02-24 C C+
2026-01-03 C+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 58 Grade B
Profitability
75
Balance Sheet
37
Earnings Quality
76
Growth
65
Value
41
Momentum
90
Safety
50
Cash Flow
48
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. SHC scores highest in Momentum (90/100) and lowest in Balance Sheet (37/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.90
Grey Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓
Beneish M-Score
-2.55
Unlikely Manipulator
Ohlson O-Score
-6.28
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BB+
Score: 47.1/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.78x
Accruals: -3.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. SHC scores 1.90, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. SHC scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. SHC's score of -2.55 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. SHC's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. SHC receives an estimated rating of BB+ (score: 47.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). SHC's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
31.78x
PEG
0.06x
P/S
4.27x
P/B
7.82x
P/FCF
46.03x
P/OCF
17.60x
EV/EBITDA
13.03x
EV/Revenue
5.78x
EV/EBIT
17.24x
EV/FCF
63.24x
Earnings Yield
3.20%
FCF Yield
2.17%
Shareholder Yield
0.00%
Graham Number
$5.43
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 31.8x earnings, SHC commands a growth premium. Graham's intrinsic value formula yields $5.43 per share, 236% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.619
NI / EBT
×
Interest Burden
0.648
EBT / EBIT
×
EBIT Margin
0.335
EBIT / Rev
×
Asset Turnover
0.373
Rev / Assets
×
Equity Multiplier
5.543
Assets / Equity
=
ROE
27.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. SHC's ROE of 27.8% is driven by financial leverage (equity multiplier: 5.54x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$21.84
Price/Value
0.81x
Margin of Safety
18.74%
Premium
-18.74%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with SHC's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. SHC trades at a -19% premium to its adjusted intrinsic value of $21.84, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 31.8x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1472 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$18.22
Median 1Y
$14.92
5th Pctile
$6.23
95th Pctile
$35.91
Ann. Volatility
54.2%
Analyst Target
$25.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Michael B. Petras,
Jr. Chairman and CEO
$1,130,699 $8,022,400 $10,656,063
Jonathan Lyons SVP,
CFO
$536,539 $2,087,272 $3,086,383
Alexander Dimitrief SVP
mer SVP and General Counsel
$600,000 $1,547,623 $2,459,612
Michael P. Rutz
President of Sterigenics
$500,000 $1,341,266 $2,180,029

CEO Pay Ratio

126:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,656,063
Avg Employee Cost (SGA/emp): $84,254
Employees: 3,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
3,000
0.0% YoY
Revenue / Employee
$387,872
Rev: $1,163,617,000
Profit / Employee
$25,983
NI: $77,949,000
SGA / Employee
$84,254
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 7.1% 22.5% 24.7% 21.5% 21.6% -49.9% -52.1% -50.9% -62.4% 12.9% 13.9% 9.5% 16.7% 10.5% 5.9% 5.1% 10.9% 15.4% 22.7% 27.8% 27.78%
ROA 1.4% 4.2% 4.9% 4.4% 4.4% -7.9% -8.4% -9.1% -10.5% 1.6% 1.7% 1.3% 2.3% 1.4% 0.8% 0.8% 1.7% 2.5% 3.7% 5.0% 5.01%
ROIC 5.0% 7.4% 7.4% 7.1% 7.0% 9.9% 8.8% 7.0% 7.5% 5.4% 5.8% 5.3% 6.6% 4.7% 3.5% 3.2% 6.2% 8.2% 9.4% 10.6% 10.59%
ROCE 7.2% 9.5% 10.0% 9.3% 9.6% -7.0% -6.6% -6.3% -7.3% 8.6% 9.2% 8.9% 10.2% 9.7% 8.8% 8.6% 9.6% 10.1% 11.7% 13.2% 13.25%
Gross Margin 55.5% 55.5% 54.4% 56.4% 54.7% 56.3% 50.5% 54.7% 55.5% 58.0% 51.2% 55.2% 55.4% 56.6% 53.2% 56.6% 57.0% 54.7% 51.4% 55.4% 55.38%
Operating Margin 29.0% 27.5% 22.6% 26.8% 25.4% 23.9% 15.1% 24.8% 28.9% 33.5% 21.4% 27.8% 28.2% 30.0% 22.4% 30.0% 35.7% 44.9% 30.9% 33.2% 33.23%
Net Margin 12.1% 14.9% 12.9% 11.4% 10.1% -1.3% 1.3% 9.2% -5.2% 12.5% 2.5% 3.2% 6.0% 4.2% -5.2% 2.7% 15.5% 11.5% 9.5% 16.7% 16.69%
EBITDA Margin 42.8% 46.6% 38.7% 37.2% 40.8% -1.2% 33.5% 41.0% 30.1% 48.0% 37.6% 34.5% 44.6% 43.5% 26.3% 32.3% 44.5% 48.2% 38.9% 45.4% 45.36%
FCF Margin 17.2% 19.3% 16.6% 13.0% 9.1% 9.5% 7.1% -35.0% -38.4% -34.6% -35.0% 2.9% 9.1% 3.9% 9.4% 9.9% 7.4% 12.7% 8.0% 9.1% 9.14%
OCF Margin 26.1% 30.2% 28.8% 26.3% 24.4% 27.7% 26.5% -13.6% -16.0% -14.1% -16.0% 20.6% 25.0% 20.2% 24.2% 23.5% 20.7% 24.5% 21.8% 23.9% 23.89%
ROE 3Y Avg snapshot only 12.91%
ROE 5Y Avg snapshot only -1.16%
ROA 3Y Avg snapshot only 2.33%
ROIC 3Y Avg snapshot only 4.14%
ROIC Economic snapshot only 9.38%
Cash ROA snapshot only 8.79%
Cash ROIC snapshot only 11.28%
CROIC snapshot only 4.31%
NOPAT Margin snapshot only 22.43%
Pretax Margin snapshot only 21.72%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 20.26%
SBC / Revenue snapshot only 3.06%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 196.49 56.37 44.36 44.08 15.64 -10.00 -19.39 -19.88 -13.72 92.93 62.19 84.23 67.40 87.79 133.24 132.27 81.38 64.82 35.01 31.29 31.781
P/S Ratio 8.06 7.07 6.34 5.65 1.92 2.33 5.13 5.46 4.25 4.55 3.17 3.08 4.26 3.54 2.99 2.83 3.92 4.34 3.47 4.21 4.272
P/B Ratio 13.90 11.24 9.44 8.63 3.15 6.67 14.03 12.75 11.16 10.76 7.95 7.99 10.14 9.63 7.98 6.21 8.19 8.34 6.63 7.68 7.822
P/FCF 46.78 36.73 38.23 43.38 21.12 24.44 72.37 -15.60 -11.06 -13.16 -9.05 104.52 46.89 90.13 31.78 28.67 53.05 34.23 43.30 46.03 46.033
P/OCF 30.84 23.40 22.02 21.48 7.88 8.40 19.35 — — — — 14.95 17.05 17.53 12.33 12.02 18.93 17.69 15.89 17.60 17.601
EV/EBITDA 26.71 20.73 18.52 17.96 8.84 -228.15 -190.93 -248.94 -121.05 16.73 12.90 13.14 14.67 13.50 12.86 12.50 15.20 15.62 12.44 13.03 13.026
EV/Revenue 9.95 8.92 8.12 7.40 3.60 3.96 6.83 7.58 6.35 6.49 5.10 4.99 6.09 5.43 4.83 4.62 5.64 6.00 5.11 5.78 5.777
EV/EBIT 47.84 33.25 28.74 28.58 13.90 -24.38 -36.58 -40.80 -30.60 27.34 20.55 21.26 22.66 21.43 21.24 20.30 22.87 23.02 17.15 17.24 17.244
EV/FCF 57.73 46.32 48.98 56.79 39.56 41.56 96.30 -21.64 -16.52 -18.76 -14.59 169.54 67.06 138.07 51.41 46.86 76.29 47.29 63.82 63.24 63.235
Earnings Yield 0.5% 1.8% 2.3% 2.3% 6.4% -10.0% -5.2% -5.0% -7.3% 1.1% 1.6% 1.2% 1.5% 1.1% 0.8% 0.8% 1.2% 1.5% 2.9% 3.2% 3.20%
FCF Yield 2.1% 2.7% 2.6% 2.3% 4.7% 4.1% 1.4% -6.4% -9.0% -7.6% -11.0% 1.0% 2.1% 1.1% 3.1% 3.5% 1.9% 2.9% 2.3% 2.2% 2.17%
PEG Ratio snapshot only 0.055
EV/OCF snapshot only 24.178
EV/Gross Profit snapshot only 10.558
Acquirers Multiple snapshot only 15.942
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $5.43
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.52 2.15 2.58 2.81 3.00 0.81 1.54 2.73 2.59 2.42 3.20 2.93 2.88 2.75 2.46 2.47 2.38 2.46 2.82 2.80 2.796
Quick Ratio 2.24 1.81 2.27 2.53 2.74 0.77 1.46 2.52 2.40 2.21 2.86 2.59 2.61 2.50 2.19 2.23 2.16 2.24 2.52 2.53 2.528
Debt/Equity 3.47 3.12 2.84 2.89 3.02 5.80 6.44 5.56 6.16 5.24 5.46 5.55 5.01 5.81 5.67 4.60 4.14 3.75 3.65 3.41 3.407
Net Debt/Equity 3.26 2.94 2.65 2.67 2.75 4.67 4.64 4.93 5.51 4.58 4.86 4.97 4.36 5.12 4.93 3.95 3.59 3.18 3.14 2.87 2.871
Debt/Assets 0.67 0.66 0.64 0.65 0.65 0.65 0.68 0.76 0.77 0.74 0.77 0.77 0.75 0.77 0.76 0.73 0.71 0.70 0.70 0.69 0.686
Debt/EBITDA 5.41 4.56 4.35 4.59 4.53 -116.70 -65.80 -78.24 -44.76 5.72 5.50 5.63 5.07 5.32 5.64 5.65 5.34 5.09 4.64 4.20 4.205
Net Debt/EBITDA 5.07 4.29 4.06 4.24 4.12 -94.00 -47.45 -69.40 -40.04 4.99 4.89 5.04 4.41 4.69 4.91 4.85 4.63 4.31 4.00 3.54 3.544
Interest Coverage 1.77 3.37 4.27 4.32 4.06 -2.03 -1.87 -1.57 -1.55 1.74 1.72 1.56 1.81 1.69 1.54 1.56 1.75 1.95 2.37 2.84 2.842
Equity Multiplier 5.22 4.76 4.42 4.46 4.63 8.90 9.45 7.35 8.04 7.05 7.13 7.23 6.70 7.59 7.48 6.29 5.79 5.38 5.20 4.97 4.968
Cash Ratio snapshot only 1.543
Debt Service Coverage snapshot only 3.763
Cash to Debt snapshot only 0.157
FCF to Debt snapshot only 0.049
Defensive Interval snapshot only 900.4 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.33 0.34 0.34 0.34 0.36 0.34 0.32 0.33 0.34 0.34 0.33 0.36 0.36 0.35 0.36 0.36 0.36 0.37 0.38 0.37 0.373
Inventory Turnover 10.72 9.34 10.72 11.00 11.90 9.77 9.69 10.94 12.04 11.05 9.87 9.85 10.97 10.22 8.83 8.49 9.32 10.01 8.64 9.03 9.034
Receivables Turnover 8.19 8.76 7.84 7.09 8.12 8.86 7.56 7.03 7.13 7.88 9.01 8.46 8.18 7.64 9.26 8.64 7.43 8.32 8.08 7.52 7.524
Payables Turnover 7.75 6.59 7.54 6.73 7.89 6.08 7.65 7.40 7.67 6.50 7.84 8.20 7.86 7.90 7.54 7.80 7.66 7.79 7.29 6.69 6.688
DSO 45 42 47 52 45 41 48 52 51 46 40 43 45 48 39 42 49 44 45 49 48.5 days
DIO 34 39 34 33 31 37 38 33 30 33 37 37 33 36 41 43 39 36 42 40 40.4 days
DPO 47 55 48 54 46 60 48 49 48 56 47 45 46 46 48 47 48 47 50 55 54.6 days
Cash Conversion Cycle 32 25 32 30 29 19 38 36 34 23 31 36 31 37 32 38 41 33 37 34 34.3 days
Fixed Asset Turnover snapshot only 1.015
Operating Cycle snapshot only 88.9 days
Cash Velocity snapshot only 3.409
Capital Intensity snapshot only 2.719
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — 3.3% 1.2% 42.6% 9.5% 7.8% 3.3% 0.6% -0.3% 4.5% 9.0% 12.5% 13.1% 4.9% 2.8% 2.4% 2.7% 5.7% 7.4% 8.1% 8.15%
Net Income — 3.7% 5.2% 11.8% 2.3% -3.0% -2.9% -3.2% -3.5% 1.2% 1.2% 1.1% 1.2% -13.6% -54.8% -40.1% -21.7% 75.6% 3.7% 5.8% 5.81%
EPS — 3.4% 5.1% 11.7% 2.3% -3.0% -2.9% -3.1% -3.5% 1.2% 1.2% 1.1% 1.2% -14.1% -54.7% -40.3% -22.0% 74.6% 3.7% 5.7% 5.75%
FCF — 89.7% 3.3% 38.4% -42.1% -46.7% -55.8% -3.7% -5.2% -4.8% -6.4% 1.1% 1.3% 1.1% 1.3% 2.4% -16.4% 2.4% -8.4% 0.2% 0.23%
EBITDA — 7.1% 2.4% 66.1% 19.9% -1.0% -1.1% -1.1% -1.1% 24.4% 13.1% 15.0% 9.9% 8.7% -2.4% -0.3% -8.2% 1.0% 17.5% 29.8% 29.76%
Op. Income — 3.9% 1.7% 45.2% 4.9% -3.3% -13.5% -14.5% -8.6% 11.4% 29.9% 41.0% 35.1% 7.6% 1.7% 1.0% 9.3% 32.0% 40.1% 40.8% 40.75%
OCF Growth snapshot only 9.97%
Asset Growth snapshot only 2.80%
Equity Growth snapshot only 30.19%
Debt Growth snapshot only -3.47%
Shares Change snapshot only 0.84%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — 69.1% 35.9% 17.3% 7.3% 5.7% 5.0% 5.0% 5.0% 5.1% 6.4% 7.6% 7.60%
Revenue 5Y — — — — — — — — — — — — — — — — — 39.9% 22.6% 12.3% 12.30%
EPS 3Y — — — — — — — — — — — 59.2% 23.0% -28.0% -43.6% -42.6% -23.7% — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — 74.6% 74.61%
Net Income 3Y — — — — — — — — — — — 60.2% 23.9% -27.6% -43.4% -42.2% -23.2% — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — 75.7% 75.71%
EBITDA 3Y — — — — — — — — — 1.0% 51.5% 20.1% 11.2% 3.3% -0.3% 1.3% 1.8% — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — 55.3% 31.9% 17.5% 17.49%
Gross Profit 3Y — — — — — — — — — 68.5% 35.9% 16.9% 6.9% 5.1% 4.7% 5.0% 5.4% 5.0% 6.6% 8.0% 7.96%
Gross Profit 5Y — — — — — — — — — — — — — — — — — 39.9% 22.6% 11.9% 11.88%
Op. Income 3Y — — — — — — — — — 74.2% 44.3% 20.5% 9.0% 5.1% 4.5% 6.8% 10.5% 16.5% 22.8% 26.1% 26.07%
Op. Income 5Y — — — — — — — — — — — — — — — — — 49.6% 33.7% 20.0% 20.01%
FCF 3Y — — — — — — — — — — — -29.3% -13.3% -37.8% -13.1% -4.3% -2.1% 15.6% 10.8% — —
FCF 5Y — — — — — — — — — — — — — — — — — 1.4% 20.7% 4.0% 3.97%
OCF 3Y — — — — — — — — — — — 13.1% 5.7% -7.6% -0.9% 1.1% -0.6% 0.9% -0.3% — —
OCF 5Y — — — — — — — — — — — — — — — — — 67.2% 27.2% 13.2% 13.23%
Assets 3Y — — — — — — — — — 4.3% 3.3% 2.4% 4.7% 3.3% 3.0% 4.2% 4.3% 1.5% -1.8% 2.5% 2.45%
Assets 5Y — — — — — — — — — — — — — — — — — 3.4% 3.1% 3.0% 3.01%
Equity 3Y — — — — — — — — — -0.6% -2.5% -6.9% -3.7% -11.6% -13.6% -7.0% -3.2% 20.1% 19.9% 16.7% 16.74%
Book Value 3Y — — — — — — — — — -4.3% -3.1% -7.4% -4.3% -12.1% -14.0% -7.6% -3.9% 19.2% 19.3% 16.1% 16.06%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — — 0.82 0.79 0.76 0.73 0.72 0.76 0.84 0.87 0.99 0.96 0.88 0.86 0.80 0.86 0.95 0.950
Earnings Stability — — — — — 0.29 0.33 0.47 0.57 0.00 0.01 0.05 0.05 0.02 0.00 0.00 0.00 0.08 0.07 0.07 0.075
Margin Stability — — — — — 1.00 0.99 0.98 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 1.00 0.99 0.988
Rev. Growth Consistency 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 1 1 1 1 1 1 0 0 0 0 0 0 0 0 1 1 1 1 1 1
Earnings Persistence — — — — — 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness — — — 0.00 0.00 — — — — — — — — 0.85 0.25 0.50 0.76 0.45 0.00 0.00 0.000
ROE Trend — — — — — -0.72 -0.79 -0.75 -0.95 0.35 0.38 0.32 0.46 0.39 0.36 0.32 0.43 0.02 0.10 0.17 0.175
Gross Margin Trend — — — — — -0.00 -0.01 -0.01 -0.01 -0.01 -0.00 0.00 0.00 -0.01 0.00 0.01 0.01 0.01 -0.00 -0.01 -0.006
FCF Margin Trend — — — — — -0.01 -0.06 -0.48 -0.52 -0.49 -0.47 0.14 0.24 0.16 0.23 0.26 0.22 0.28 0.21 0.03 0.027
Sustainable Growth Rate 7.1% 22.5% 24.7% 21.5% 21.6% — — — — 12.9% 13.9% 9.5% 16.7% 10.5% 5.9% 5.1% 10.9% 15.4% 22.7% 27.8% 27.78%
Internal Growth Rate 1.4% 4.4% 5.1% 4.6% 4.6% — — — — 1.7% 1.7% 1.3% 2.3% 1.5% 0.8% 0.8% 1.8% 2.5% 3.9% 5.3% 5.28%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 6.37 2.41 2.01 2.05 1.98 -1.19 -1.00 0.50 0.52 -2.88 -3.13 5.64 3.95 5.01 10.81 11.00 4.30 3.66 2.20 1.78 1.778
FCF/OCF 0.66 0.64 0.58 0.50 0.37 0.34 0.27 2.57 2.40 2.46 2.19 0.14 0.36 0.19 0.39 0.42 0.36 0.52 0.37 0.38 0.382
FCF/Net Income snapshot only 0.680
OCF/EBITDA snapshot only 0.539
CapEx/Revenue 8.9% 11.0% 12.2% 13.3% 15.3% 18.2% 19.4% 21.4% 22.4% 20.5% 19.0% 17.6% 15.9% 16.3% 14.8% 13.6% 13.3% 11.9% 13.8% 14.8% 14.76%
CapEx/Depreciation snapshot only 1.360
Accruals Ratio -0.07 -0.06 -0.05 -0.05 -0.04 -0.17 -0.17 -0.05 -0.05 0.06 0.07 -0.06 -0.07 -0.06 -0.08 -0.08 -0.06 -0.07 -0.04 -0.04 -0.039
Sloan Accruals snapshot only -0.024
Cash Flow Adequacy snapshot only 1.619
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 1.2% 1.0% 1.2% 1.2% — — — — 8.0% 7.5% 10.2% 5.8% 10.0% 32.4% 33.6% 14.6% 4.7% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 0.3% 0.2% 0.1% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 0.3% 0.2% 0.1% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.2% 0.3% 0.2% 0.1% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.45 0.67 0.66 0.64 0.63 0.96 0.92 0.90 0.91 0.48 0.49 0.43 0.53 0.39 0.28 0.26 0.45 0.53 0.57 0.62 0.619
Interest Burden (EBT/EBIT) 0.43 0.70 0.77 0.77 0.75 1.49 1.53 1.64 1.64 0.43 0.42 0.36 0.45 0.41 0.35 0.36 0.43 0.49 0.58 0.65 0.648
EBIT Margin 0.21 0.27 0.28 0.26 0.26 -0.16 -0.19 -0.19 -0.21 0.24 0.25 0.23 0.27 0.25 0.23 0.23 0.25 0.26 0.30 0.34 0.335
Asset Turnover 0.33 0.34 0.34 0.34 0.36 0.34 0.32 0.33 0.34 0.34 0.33 0.36 0.36 0.35 0.36 0.36 0.36 0.37 0.38 0.37 0.373
Equity Multiplier 5.22 5.35 5.08 4.91 4.90 6.31 6.23 5.61 5.94 7.87 8.19 7.29 7.30 7.31 7.30 6.72 6.21 6.27 6.11 5.54 5.543
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $0.13 $0.42 $0.49 $0.44 $0.44 $-0.83 $-0.92 $-0.95 $-1.09 $0.18 $0.19 $0.14 $0.25 $0.16 $0.09 $0.08 $0.19 $0.27 $0.41 $0.57 $0.57
Book Value/Share $1.88 $2.09 $2.29 $2.27 $2.17 $1.25 $1.28 $1.48 $1.34 $1.57 $1.51 $1.49 $1.65 $1.42 $1.46 $1.79 $1.92 $2.12 $2.16 $2.31 $2.33
Tangible Book/Share $-4.24 $-4.05 $-3.81 $-3.65 $-3.53 $-4.43 $-4.29 $-4.06 $-4.10 $-3.83 $-3.75 $-3.67 $-3.45 $-3.49 $-3.42 $-3.13 $-2.93 $-2.74 $-2.62 $-2.41 $-2.41
Revenue/Share $3.24 $3.33 $3.42 $3.47 $3.55 $3.58 $3.49 $3.45 $3.52 $3.70 $3.79 $3.86 $3.92 $3.86 $3.90 $3.94 $4.01 $4.06 $4.13 $4.22 $4.26
FCF/Share $0.56 $0.64 $0.57 $0.45 $0.32 $0.34 $0.25 $-1.21 $-1.35 $-1.28 $-1.33 $0.11 $0.36 $0.15 $0.37 $0.39 $0.30 $0.52 $0.33 $0.39 $0.39
OCF/Share $0.85 $1.01 $0.98 $0.91 $0.87 $0.99 $0.93 $-0.47 $-0.57 $-0.52 $-0.61 $0.79 $0.98 $0.78 $0.95 $0.92 $0.83 $1.00 $0.90 $1.01 $1.02
Cash/Share $0.41 $0.38 $0.43 $0.50 $0.59 $1.41 $2.29 $0.93 $0.87 $1.05 $0.92 $0.86 $1.07 $0.97 $1.07 $1.16 $1.05 $1.21 $1.10 $1.24 $1.25
EBITDA/Share $1.21 $1.43 $1.50 $1.43 $1.44 $-0.06 $-0.12 $-0.10 $-0.18 $1.44 $1.50 $1.47 $1.63 $1.55 $1.47 $1.45 $1.49 $1.56 $1.70 $1.87 $1.87
Debt/Share $6.53 $6.53 $6.52 $6.56 $6.54 $7.25 $8.21 $8.21 $8.28 $8.21 $8.26 $8.25 $8.26 $8.25 $8.28 $8.22 $7.94 $7.94 $7.89 $7.87 $7.87
Net Debt/Share $6.12 $6.15 $6.09 $6.06 $5.96 $5.84 $5.92 $7.28 $7.41 $7.17 $7.34 $7.38 $7.18 $7.28 $7.20 $7.06 $6.89 $6.73 $6.79 $6.63 $6.63
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 1.896
Altman Z-Prime snapshot only 3.240
Piotroski F-Score 4 6 8 7 7 5 2 1 2 5 5 7 7 5 7 5 6 6 7 7 7
Beneish M-Score — -2.72 -2.66 -2.72 -2.55 -3.17 -3.09 -2.62 -2.65 -2.04 -2.21 -2.86 -2.82 -2.83 -2.83 -2.76 -2.67 -2.69 -2.51 -2.55 -2.555
Ohlson O-Score snapshot only -6.283
Net-Net WC snapshot only $-6.92
EVA snapshot only $15116218.70
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB+
Credit Score 39.75 46.76 51.51 50.98 41.09 19.26 25.28 26.81 26.09 32.32 33.49 35.16 35.67 34.60 33.28 30.27 34.96 35.96 40.90 47.06 47.056
Credit Grade snapshot only 11
Credit Trend snapshot only 16.782
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 44
Sector Credit Rank snapshot only 40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms